Prognostic significance of loss of chromosome 10 in high grade gliomas.

被引：0
|
作者：
Balesaria, S
Brock, C
Bower, M
Lewis, P
Newlands, ES
Fisher, RA
机构：
[1] Charing Cross Hosp, Imperial Coll Sch Med, Dept Canc Med, London, England
[2] Charing Cross Hosp, Imperial Coll Sch Med, Dept Histopathol, London, England
来源：
BRITISH JOURNAL OF CANCER | 1999年 / 80卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P5
引用
收藏
页码：30 / 30
页数：1
相关论文
共 50 条
  • [21] Chromosome 1p loss:: A favorable prognostic factor in low-grade gliomas
    Kujas, M
    Lejeune, J
    Benouaich-Amiel, A
    Crinière, E
    Laigle-Donadey, F
    Marie, Y
    Mokhtari, K
    Polivka, M
    Bernier, M
    Chretien, F
    Couvelard, A
    Capelle, L
    Duffau, H
    Cornu, P
    Broët, P
    Thillet, J
    Carpentier, AF
    Sanson, M
    Hoang-Xuan, K
    Delattre, JY
    ANNALS OF NEUROLOGY, 2005, 58 (02) : 322 - 326
  • [22] Prognostic factors in high grade gliomas
    Gelabert-Gonzalez, Miguel
    Gonzalez-Gomez, Lara
    Aran-Echabe, Eduardo
    NEUROCIRUGIA, 2018, 29 (05): : 265 - 265
  • [23] Grading of pediatric high grade gliomas. Results from the HERBY trial
    Varlet, Pascale
    Le Teuff, Gwenael
    Le Deley, Marie-Cecile
    Giangaspero, Felice
    Haberler, Christine
    Jacques, Thomas
    Figarella-Branger, Dominique
    Pietsch, Torsten
    Andreiuolo, Felipe
    Grill, Jacques
    BRAIN PATHOLOGY, 2019, 29 : 57 - 57
  • [24] Bevacizumab plus irinotecan in patients with recurrent high grade malignant gliomas.
    Legaspi, Jairo
    Ceniceros, Lucia
    Espinos, Jaime
    Valtuena, German
    Martin, Patricia
    Castanon Alvarez, Eduardo
    Aristu, Javier
    Baraibar, Iosune
    Salas, Diego
    Sala, Pablo
    Gardeazabal, Itziar
    Zubiri Oteiza, Leyre
    Olarte, Alicia
    Gil-Bazo, Ignacio
    Dominguez, Pablo
    Pablo Fusco, Juan
    Isabel Martinez, Maria
    Aramendia, Jose M.
    Fernandez-Hidalgo, Oscar
    Santisteban, Marta
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [25] Dynamic genomic deletion expansion: A molecular marker of high grade gliomas.
    Finkelstein, SD
    Swalsky, PA
    Wilson, MM
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2005, 64 (05): : 454 - 454
  • [26] MALIGNANT TRANSFORMATION OF LOW-GRADE GLIOMAS. PROGNOSTIC IMPLICATIONS FROM MATHEMATICAL MODEL
    Bogdanska, M. U.
    Bodnar, M.
    Piotrowska, M. J.
    Murek, M.
    Schucht, P.
    Beck, J.
    Martinez-Gonzalez, A.
    Perez-Garcia, V. M.
    NEURO-ONCOLOGY, 2017, 19 : 85 - 85
  • [27] Erratum to: Prognostic significance of telomere maintenance mechanisms in pediatric high-grade gliomas
    Kathleen Dorris
    Matthew Sobo
    Arzu Onar-Thomas
    Eshini Panditharatna
    Charles B. Stevenson
    Sharon L. Gardner
    Mariko D. DeWire
    Christopher R. Pierson
    Randal Olshefski
    Sandra A. Rempel
    Stewart Goldman
    Lili Miles
    Maryam Fouladi
    Rachid Drissi
    Journal of Neuro-Oncology, 2014, 119 : 223 - 224
  • [28] Role of natural lycopene and phytonutrients along with radiotherapy and chemotherapy in high grade gliomas.
    Puri, T
    Julka, PK
    Goyal, S
    Nair, O
    Sharma, DN
    Rath, GK
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 129S - 129S
  • [29] Prognostic significance of chromosome aberrations in high-grade soft tissue sarcomas
    Mertens, F
    Strömberg, U
    Rydholm, A
    Gustafson, P
    Bauer, HCF
    Brosjö, O
    Mandahl, N
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (02) : 315 - 320
  • [30] RADIOCHEMOTHERAPY IN HIGH-GRADE GLIOMAS. IMPACT OF EXTENDING ADJUVANT CHEMOTHERAPY WITH TEMOZOLOMIDE
    Vinchon, Sandrine
    Jadaud, Eric
    Soulie, Patrick
    Menei, Philippe
    Michalak, Sophie
    Gamelin, Erick
    NEURO-ONCOLOGY, 2008, 10 (05) : 882 - 882
12345